Peter Seeberger

Peter Seeberger is a Professor of Organic Chemistry at Freie Universität Berlin and Director at the Max Planck Institute of Colloids and Interfaces, renowned for revolutionizing glycoscience through automated glycan assembly. His work bridges chemistry and biomedical applications, focusing on synthetic carbohydrate-based vaccines.

His research centers on developing rapid, automated methods for synthesizing complex glycans, enabling breakthroughs in malaria vaccine candidates and infectious disease therapeutics. This interdisciplinary approach integrates organic chemistry, immunology, and chemical engineering to decode glycan functions in cellular recognition and pathogen interactions.

• Gottfried Wilhelm Leibniz Prize (2008)
• Ryoji Noyori Prize (2017)
• Paul Karrer Gold Medal (2020)
• Klung Wilhelmy Science Award (2002)

Seeberger leads a multidisciplinary team at the Max Planck Institute, securing major grants from the European Research Council and German Research Foundation for glycan synthesis platforms. His lab collaborates globally with pharmaceutical partners to translate automated assembly into clinical antimalarial vaccines.

His research group operates state-of-the-art automated synthesis facilities, driving innovations in glycomics and personalized glycotherapeutics while training next-generation scientists in carbohydrate chemistry.